FDA Warning Letter — Sal Pharma
The FDA took a Warning Letter action against Sal Pharma on April 20, 2017 (Hyderabad, India). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Sal Pharma
- Date
- April 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Hyderabad (India)